All-new VC Sheet coming soon. Get early access
You're in!
We'll reach out soon.
Oops! Something went wrong while submitting the form.

BridgeBio

BridgeBio finds, develops, and delivers breakthrough medicines for genetic diseases. Millions worldwide are afflicted with genetic diseases, but small patient populations and industry reluctance to conduct early-stage development means that for many, treatments have not been forthcoming. We are committed to bridging this gap: between business case and scientific possibility, between patient and hope. BridgeBio creates a bridge from remarkable advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio is committed to developing leaders as well as drugs. We are looking for individuals whose passion for creating life-changing medicines will inspire hands-on engagement and the dogged pursuit of novel solutions in the face of adversity.
Founding Year
2014
Headquarters
Palo Alto
,
United States
Sector(s)
No items found.
Funding State
Pre-Seed
Seed
Series A
Series B+
Exited
Total Funding Amount
$5,630.20M
Funds that Investested

Sequoia Capital

Helps the daring build legendary companies, from idea to IPO and beyond.
Pre-Seed
Seed
Series A
Series B+
View Profile
Investors that Investested

Roelof Botha

Partner, Sequoia Capital
Seed/Early-stage and growth investor. Looks for unconventional founders to add to his impressive investment portfolio. Invested in Youtube, Evernote, Tumblr, Instagram, MongoDB, 23&Me, etc.
Pre-Seed
Seed
Series A
Series B+
View Profile

Browse All Sheets

Find lists for every type of VC
By Round
By Geography
By Sector
By Type
Sector-focused Sheets